Moderna Inc. buy UBS Group AG
Start price
26.06.23
/
50%
€111.22
Target price
26.06.24
€174.90
Performance (%)
16.06%
Price
20.05.24
€129.08
Summary
This prediction is currently active. The prediction currently has a performance of 16.06%. This prediction currently runs until 26.06.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 10.760% | 10.760% |
| iShares Core DAX® | 0.051% | 5.593% |
| iShares Nasdaq 100 | 1.808% | 7.445% |
| iShares Nikkei 225® | 2.181% | 2.815% |
| iShares S&P 500 | 1.040% | 4.975% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $191.00 price target on the stock, down previously from $221.00.
Ratings data for MRNA provided by MarketBeat